The Science of Fibroblast Cell-Based Therapies


Peer Reviewed Publications

Journal of Translational Medicine

Our Chief Scientific Officer, Thomas Ichim, Ph.D. led a team in a thorough analysis of the advantage fibroblasts exhibit over mesenchymal stem cells.

The Spine Journal

Howard An, M.D. leads a team of researchers who found that transplanting dermal fibroblasts can significantly increase the markers of disc regeneration and supported the hypothesis that the intervertebral disc is immune privileged. The study also suggests that fibroblast cell therapies can prevent the degeneration and promote the regeneration of the spinal disc.

Global Spine Journal

A team of scientists led by Howard An, M.D. proves human dermal fibroblasts are a promising future for treatment of degenerative disc disease.

Intriguing New Publications